Availability and affordability of new medicines in Latin American countries where pivotal clinical trials were conducted
Abstract Objective To assess whether new pharmaceutical products approved by the United States Food and Drug Administration (FDA) in 2011 and 2012 were registered, commercialized and sold at affordable prices in the Latin American countries where they were tested. Methods We obtained a list of new m...
Saved in:
Main Authors: | Núria Homedes (Author), Antonio Ugalde (Author) |
---|---|
Format: | Book |
Published: |
The World Health Organization,
2015-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Multisource drug policies in Latin America: survey of 10 countries
by: Homedes Núria, et al.
Published: (2005) -
Making medicines affordable: studying WHO initiatives
by: Nuria Homedes -
Clinical trials in Latin America: implications for the sustainability and safety of pharmaceutical markets and the wellbeing of research subjects
by: Núria Homedes, et al.
Published: (2016) -
Human resources: the Cinderella of health sector reform in Latin America
by: Ugalde Antonio, et al.
Published: (2005) -
Price, availability and affordability of medicines
by: Brenda S. Mhlanga, et al.
Published: (2014)